BC Craft Supply Co. Ltd. (OTCPK: CRFT.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
BC Craft Supply Co. Ltd. (OTCPK: CRFT.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.00.
trading between 0.00 and 0.00.
Tweenvest scores BC Craft Supply Co. Ltd. across four factors: quality 22/100, value 41/100. Its strongest factor is value.
CRFT.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.00
- Revenue (TTM)
- $49.09K
- P/E
- —
- EPS
- -3.86
- Dividend yield
- —
- Beta (5Y)
- 5.34
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.28M
- Employees
- —
- Next earnings
- —
About BC Craft Supply Co. Ltd.
BC Craft Supply Co. Ltd. engages in development and acquisition of nutritional product formulae and cannabinoid brands for adults recreational. Its operations include CRFT, a curator and aggregator of craft cannabis, providing advocacy and access for premium small-batch growers to Canada's cannabis market; Feelwell Brands, a cannabinoid brand licensed in the state of California; and AVA Pathways, a pre-clinical biotech company focuses on neuroplasticity and alternative ways to treat common and debilitating medical conditions such as depression, anxiety, PTSD, and substance use disorder, through the use of psychedelic-based treatments. In addition, it involved in licensing and marketing of Grizzlers and Roll Model branded pre-rolls. The company was formerly known as Pasha Brands Ltd. and changed its name to BC Craft Supply Co. Ltd. in May 2020. BC Craft Supply Co. Ltd. is based in Vancouver, Canada.
- ISIN
- CA07335D2014
- Listed since
- Nov 12, 2012
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.36 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.50 | +0.13% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.